Management of thyroid optic neuropathy

International Ophthalmology Clinics

Volumn 36, Issue 1, 1996, Pages 179-193

  Lucarelli, Mark J ^a   Shore, John W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE;

DECOMPRESSION SURGERY; DRUG EFFICACY; GRAVES DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; OPTIC NERVE DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; STEROID THERAPY; SURGICAL APPROACH;

ADRENAL CORTEX HORMONES; COMBINED MODALITY THERAPY; GRAVES DISEASE; HUMANS; OPTIC NERVE DISEASES; THYROID DISEASES; TREATMENT OUTCOME;

EID: 0029984478     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199603610-00018     Document Type: Review

References (58)

1. Trobe JD, Glaser JS, Laflamme P. Dysthyroid optic neuropathy. Arch Ophthalmol 1978;96:1199-1209
2. Hedges TR, Scheie HG. Visual field defects in exophthalmos associated with thyroid disease. Arch Ophthalmol 1955;54:885-892
3. Henderson JW. Optic neuropathy of exophthalmic goiter (Graves' disease). Arch Ophthalmol 1958;59:471-480
4. Day RM, Carroll FD. Optic nerve involvement associated with thyroid dysfunction. Arch Ophthalmol 1962;67:289-297
5. Hufnagel TJ, Hickey WF, Cobbs WH, et al. Immunohistochemical and ultrastructural studies on the exenterated orbit of a patient with Graves' disease. Ophthalmology 1984;91:1411-1419
6. Hallin ES, Feldon SE. Graves' ophthalmopathy: II. Correlation of clinical signs with measures derived from computed tomography. Br J Ophthalmol 1988;72:678-682
7. Barrett L, Glatt HJ, Burde RM, Gado MH. Optic nerve dysfunction in thyroid eye disease: CT. Radiology 1988;167:503-507
8. Feldon SE, Muramatsu S, Weiner JM. Clinical classification of Graves' ophthalmopathy. Arch Ophthalmol 1984;102:1469-1472
9. Kennerdell JS, Rosenbaum AE, El-Hoshy MH. Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography. Arch Ophthalmol 1981;99: 807-809
10. Nunery WR. Ophthalmic Graves' disease. Ophthalmol Clin North Am 1991;4: 73-87
11. Ingersheimer J. Visual changes in progressive exophthalmos. Arch Ophthalmol 1955;53:94-104
12. Day RM, Carroll FD. Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction. Trans Am Ophthalmol Soc 1967;65:41-51
13. Prummel M, Mourits M, Berghout A. Prednisone and cyclosporine in treatment of severe Graves' ophthalmopathy. N Engl J Med 1989;321:1353
14. Perros P, Weightman D, Crombie A. Azathioprine in the treatment of thyroid-associated ophthalmopathy. Acta Endocrinol 1990;122:8
15. Bigos S, Nisula B, Daniels G. Cyclophosphamide in the management of advanced Graves' ophthalmopathy. Ann Intern Med 1979;90:921
16. Donaldson SS, Bagshaw MA, Kriss JP. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 1973;37:276-285
17. Olivotto IA, Ludgate CM, Allen LH, Rootman J. Supervoltage radiotherapy for Graves' ophthalmopathy: CCABC technique and results. Int J Radiat Oncol Biol Phys 1985;11:2085-2090
18. Petersen IA, Kriss JP, McDougall IR, Donaldson SS. Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 1990;19:259-264
19. Kendall-Taylor P, Crombie AL, Stephenson AM, et al. Intravenous prednisone in the treatment of Graves' ophthalmopathy. Br Med J 1988;297:1574-1576
20. Evans WH. Prednisone therapy in ophthalmic Graves' disease. Trans Ophthalmol Soc UK 1961;81:657-662
21. Brown J, Coburn JW, Wigod RA, et al. Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease. Am J Med 1963;34:786-795
22. Werner SC. Prednisone in emergency treatment of malignant exophthalmos. Lancet 1966;1:1004-1007
23. Prummel MF, Mourits MP, Blank L, et al. Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993;342:949-954
24. Panzo GJ, Tomsak RL. A retrospective review of 26 cases of dysthyroid optic neuropathy. Am J Ophthalmol 1983;96:190-194
25. Kazim M, Trokel S, Moore S. Treatment of acute Graves' orbitopathy. Ophthalmology 1991;98:1443-1448
26. Bartalena L, Marcocci C, Chiovato L, et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983;56:1139-1144
27. Ravin JG, Sisson JC, Knapp WT. Orbital radiation for the ocular changes of Graves' disease. Am J Ophthalmol 1975;79:285-288
28. Konishi J, Iida Y, Kasagi K, et al. Clinical evaluation of radiotherapy for Graves' ophthalmopathy. Endocrinol Japon 1986;33:637-644
29. Sandier HM, Rubenstein JH, Fowble BL, et al. Results of radiotherapy for thyroid ophthalmopathy. Int J Radiat Oncol Biol Phys 1989;17:823-827
30. Palmer D, Greenberg P, Cornell P, Parker RG. Radiation therapy for Graves' ophthalmopathy: a retrospective analysis. Int J Radiat Oncol Biol Phys 1987;13: 1815-1820
31. Hurbli T, Char DH, Harris J, et al. Radiation therapy for thyroid eye diseases. Am J Ophthalmol 1985;99:633-637
32. Wiersinga WM, Smit T, Schuster-Uittenhoeve AL, et al. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy. Ophthalmologica 1988;197:75-84
33. Donaldson SS, Kriss JP, McDougall IR, Bagshaw MA. Orbital irradiation in the treatment of Graves' ophthalmopathy - results in 141 consecutive patients. Int J Radiat Oncol Biol Phys 1982;8:112-113
34. van Ouwerkerk BM, Wijngaarde R, Hennemann G, et al. Radiotherapy of severe ophthalmic Graves' disease. J Endocrinol Invest 1985;8:241-247
35. Marcocci C, Bartalena L, Bogazzi F, et al. Orbital irradiation combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study. J Endocrinol Invest 1991;14:853-860
36. Dollinger J. Die druchenHastung der augenhöhle durch entfernung der aüsseren orbitalwand bei hochgradigen exophthalmus und konsekutiver hornhauterkrantung. Dtsch Med Wochenschr 1911;37:1888-1890
37. Naffziger HC. Progressive exophthalmos following thyroidectomy: its pathology and treatment. Ann Surg 1931;94:582-586
38. Walsh TE, Ogura JH. Transantral orbital decompression for malignant exophthalmos. Laryngoscope 1957;67:544-568
39. Ogura JH, Lucente FE. Surgical results of orbital decompression for malignant exophthalmos. Laryngoscope 1974;84:637-644
40. DeSanto LW. The total rehabilitation of Graves' ophthalmopathy. Laryngoscope 1980;90:1652-1678
41. Warren JD, Spector JG, Burde R. Long-term follow-up and recent observations on 305 cases of orbital decompression for dysthyroid orbitopathy. Laryngoscope 1989;99:35-40
42. Garrity JA, Fatourechi V, Bergstralh EJ, et al. Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy. Am J Ophthalmol 1993;116:533-547
43. Weisman RA, Osguthorpe JD. Orbital decompression in Graves' disease. Arch Otolaryngol Head Neck Surg 1994;120:831-834
44. Baylis HI, Call NB, Shibata CS. The transantral orbital decompression (Ogura technique) as performed by the ophthalmologist. Ophthalmology 1980;87:1005-1012
45. Gorman CA, DeSanto LW, MacCarty CS, Riley FC. The optic neuropathy of Graves' disease: treatment by transantral or transfrontal orbital decompression. N Engl J Med 1974;290:70-75
46. Carter KD, Freuh BR, Hessburg TP, Musch DC. Long-term efficacy of orbital decompression for compressive optic neuropathy of Graves' eye disease. Ophthalmology 1991;98:1435-1442
47. Girod DA, Orcutt JC, Cummings CW. Orbital decompression in preservation of vision in Graves' ophthalmopathy. Arch Otolaryngol Head Neck Surg 1993;119: 229-233
48. Fells P. Orbital decompression for severe dysthyroid eye disease. Br J Ophthalmol 1987;71:107-111
49. Fatourechi V, Bartley GB, Garrity JA. Transfrontal orbital decompression after failure of transantral decompression in optic neuropathy. Mayo Clin Proc 1993;68: 552-555
50. Leatherbarrow B, Lendrum J, Mahaffey PJ, et al. Three wall orbital decompression for Graves' ophthalmopathy via a coronal approach. Eye 1991;5:456-465
51. Kennerdell JS, Maroon JC. An orbital decompression for severe dysthyroid exophthalmos. Ophthalmology 1982;89:467-472
52. Mourits MP, Koornneef L, Wiersinga WM, et al. Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach. Ophthalmology 1990;97:636-641
53. Hurwitz JJ, Freeman JL, Eplett CJ, et al. Ethmoidectomy decompression for the treatment of Graves' optic neuropathy. Can J Ophthalmol 1992;27:283-287
54. Linberg JV, Anderson RL. Transorbital decompression: indications and results. Arch Ophthalmol 1981;99:113-119
55. Kennedy DW, Goodstein ML, Miller NR, Zinreich SJ. Endoscopic transantral orbital decompression. Arch Otolaryngol Head Neck Surg 1990;116:275-282
56. Anderson RL, Linberg JV. Transorbital approach to decompression in Graves' disease. Arch Ophthalmol 1981;99:120-124
57. Fatourechi V, Bergstralh EJ, Garrity JA, et al. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy. Mayo Clin Proc 1994;69: 841-848
58. McCord CD. Current trends in orbital decompression. Ophthalmology 1985;92: 21-33